author-photo

Mrinal M. Gounder

Memorial Sloan Kettering Cancer Center
Cornell University

157

Papers

6858

Citations

Citation Trend

Filter By

Papers (157) Sort By

Journal Conference Others

1548P A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (1)
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.

2021 Quality of Life Research
Show All
- Source
- Cite
- Save
Citations (1)
Percutaneous Cryoablation Provides Disease Control for Extra-Abdominal Desmoid-Type Fibromatosis Comparable with Surgical Resection.

2021 Annals of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1527MO Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pseudoaneurysm within a desmoid tumor in an extremity: report of 2 cases.

2021 Skeletal Radiology
Show All
- Source
- Cite
- Save
Citations (0)
A phase I dose-escalation study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced solid tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers.

2021 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (1)
Checkpoint inhibitors and radiotherapy in refractory malignant melanocytic schwannoma with Carney complex: first evidence of efficacy.

2021 Case Reports
Show All
- Source
- Cite
- Save
Citations (0)